I try to never say never - but you are quite likely correct in at least the first part of this statement:
There's no chance whatsoever of $100 a share in 2015. We will be very lucky to see $8 a share next year.
The second part is (indeed) a possibility, and I would argue a significant probability during 2015 IF Ebolacide2 shows significant efficacy, and when the Shelton plant goes online.
Assuming that the IND is filed by at least the last quarter of 2015 - that potential even could also push shareprices here up over $8-10/share IMO.